Omada Health (NASDAQ:OMDA) Rating Increased to Hold at Baird R W

Key Points

• Omada Health (NASDAQ:OMDA) has been upgraded to a "hold" rating by Baird R W, reflecting a growing consensus among analysts about the stock's performance.
• The company recently reported earnings that missed estimates, posting a loss of ($0.22) per share against analysts' expectations of ($0.15) but exceeded revenue estimates with $61.37 million.
• Despite the earnings miss, seven analysts rate the stock as a buy, while two have given it a hold rating, suggesting a strong interest from institutional investors.

Omada Health (NASDAQ:OMDA - Get Free Report) was upgraded by analysts at Baird R W to a "hold" rating in a note issued to investors on Friday,Zacks.com reports.

OMDA has been the subject of several other reports. Robert W. Baird started coverage on Omada Health in a research note on Friday. They issued a "neutral" rating and a $24.00 price objective for the company. JPMorgan Chase & Co. began coverage on Omada Health in a research note on Tuesday, July 1st. They issued an "overweight" rating and a $19.00 price objective on the stock. Morgan Stanley began coverage on Omada Health in a research note on Tuesday, July 1st. They issued an "overweight" rating and a $25.00 price objective on the stock. The Goldman Sachs Group started coverage on Omada Health in a research note on Tuesday, July 1st. They issued a "buy" rating and a $29.00 price objective on the stock. Finally, Wall Street Zen raised Omada Health to a "hold" rating in a research report on Monday, June 16th. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $24.50.

Omada Health Stock Up 2.4%

Shares of OMDA stock opened at $24.28 on Friday. The company's 50-day moving average price is $19.68. Omada Health has a fifty-two week low of $14.14 and a fifty-two week high of $28.40.

Omada Health (NASDAQ:OMDA - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.07). The company had revenue of $61.37 million during the quarter, compared to analyst estimates of $55.17 million. Omada Health has set its FY 2025 guidance at EPS.

Hedge Funds Weigh In On Omada Health

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the second quarter valued at $32,000. Ilex Capital Partners UK LLP bought a new stake in Omada Health in the second quarter valued at about $201,000. Sandia Investment Management LP acquired a new stake in shares of Omada Health during the second quarter worth about $366,000. XTX Topco Ltd acquired a new stake in shares of Omada Health during the second quarter worth about $414,000. Finally, Walleye Capital LLC acquired a new stake in shares of Omada Health during the second quarter worth about $458,000.

About Omada Health

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.